Table 4.
Pulmonary embolism and clinical outcomes based on clinical severity.
| Characteristics |
Pulmonary thromboembolism Severity |
|||
|---|---|---|---|---|
| Massive(n=40) | Sub massive(n=36) | Low risk(n=64) | p value | |
| Age (year) | 47 ± 14 | 50 ± 16 | 52 ± 15 | 0.003 |
| Sex | ||||
| Female | 16 (40%) | 11 (30.60%) | 30 (46.90%) | 0.279 |
| Male | 24 (60%) | 25 (69.40%) | 34 (53.10%) | |
| Dyspnea | ||||
| NYHA I | 4 (10%) | 0 (0%) | 19 (29.70%) | Stat test could not be performed |
| NYHA II | 3 (7.50%) | 11 (30.60%) | 17 (26.60%) | |
| NYHA III | 16 (40%) | 16 (44.40)% | 21 (32.80%) | |
| NYHA IV | 17 (42.50%) | 9 (25%) | 7 (10.90%) | |
| Syncope | 6 (15%) | 4 (11.10%) | 4 (6.30%) | 0.340 |
| Chest pain | 12 (30%) | 16 (44.40%) | 21 (32.80%) | 0.371 |
| Cough | 11 (27.50%) | 12 (33.30%) | 22 (34.40%) | 0.754 |
| Hemoptysis | 3 (7.50%) | 4 (11.10%) | 7 (10.90%) | 0.823 |
| Palpitations | 6 (15%) | 7 (19.40%) | 6 (9.40% | 0.352 |
| Deep venous thrombosis | 20 (50%) | 19 (52.80%) | 35 (54.70%) | 0.897 |
| Diabetes | 15 (37.50%) | 15 (41.70% | 26 (40.60%) | 0.925 |
| Malignancy | 6 (15%) | 7 (19.40%) | 10 (15.60%) | 0.849 |
| Hypertension | 14 (35%) | 15 (41.70%) | 21 (32.80%) | 0.671 |
| Recent surgery | 9 (22.50%) | 8 (22.20%) | 19 (29.70%) | 0.614 |
| Pregnancy | 1 (2.50%) | 1 (2.80%) | 1 (1.60%) | 0.906 |
| Chronic kidney disease | 6 (15%) | 3 (3.80%) | 4 (6.30%) | 0.318 |
| Chronic obstructive pulmonary disease | 7 (17.50%) | 2 (5.60%) | 1 (1.60%) | 0.008 |
| Trauma | 7 (17.50%) | 6 (16.70%) | 11 (17.20%) | 0.995 |
| Travel | 1 (2.50%) | 0 (0%) | 0 (0%) | 0.284 |
| Duration (days) | 4 ± 5 | 6 ± 4 | 6 ± 7 | 0.287 |
| Acute worsening (days) | 3 ± 2 | 4 ± 2 | 3 ± 5 | 0.154 |
| Pulmonary embolism severity index | 134 ± 32 | 90 ± 27 | 64 ± 20 | <0.001 |
| Outcome | ||||
| Live | 11 (27.50%) | 33 (91.70%) | 60 (93.80%) | <0.001 |
| Death | 29 (72.50%) | 3 (8.30%) | 4 (6.30%) | |
| Pulmonary embolism severity index | ||||
| Live | 119.91 ± 21.585 | 89.64 ± 27.26 | 64.37 ± 20.54 | Not significant |
| Death | 139.83 ± 33.37 | 97.33 ± 25.15 | 61 ± 17.91 | |
| Lysed | ||||
| Thrombolyzed | 25 (62.50%) | 23 (63.90%) | 2 (3.10%) | <0.001 |
| Not thrombolyzed | 15 (37.50%) | 13 (36.10%) | 62 (96.90%) | |
| Bleeding | ||||
| Yes | 5 (12.50% | 5 (13.90%) | 3 (4.70%) | 0.223 |
| No | 35 (87.50%) | 31 (86.10%) | 61 (95.30%) | |
| Thrombolyzed | ||||
| Live | 10 (40%)a | 22 (95.7%)b | 2 (100 %)c | |
| Death | 15 (60%)a | 1 (4.3%)b | 0 (0.1%)c | |
| Not thrombolyzed | ||||
| Live | 1 (6.7%)a | 11 (84.6%)b | 58 (58.1 %)c | |
| Death | 14 (93.3%)a | 2 (15.4%)b | 4 (3.9%)c | |
ap=0.022.
b,cp=not significant.